Related Experiment Video
Updated: May 8, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation
Carlos Rosa-Baez1, Gonzalo Borrego-Yaniz1, Inmaculada Rodriguez-Martin1
1Department of Cell Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain.
Insights
This study reveals shared genetic factors between COVID-19 and systemic sclerosis (SSc), highlighting common immune and fibrotic pathways. Findings suggest potential new therapeutic targets for both conditions.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- Coronavirus disease 2019 (COVID-19) and systemic sclerosis (SSc) exhibit overlapping clinical features, immune responses, and treatments.
- These similarities suggest a potential shared genetic basis, as observed in other immune-mediated inflammatory diseases.
Purpose of the Study:
- To investigate the shared genetic architecture between COVID-19 and SSc for the first time.
- To identify common genetic variants influencing susceptibility and severity in both diseases.
Main Methods:
- Utilized genomic data from large European cohorts for COVID-19 (n=2,597,856) and SSc (n=26,679).
- Performed cross-trait meta-analyses of over 9.3 million single nucleotide polymorphisms (SNPs).
- Conducted functional annotation and drug repurposing analyses to identify causal genes and therapeutic strategies.
Main Results:
- Identified 19 non-HLA pleiotropic loci, including novel associations (BMP1, PPARG) and 12 new shared loci.
- Functional annotation highlighted regulatory roles and implicated genes in fibrotic and inflammatory pathways.
- Observed antagonistic pleiotropy in IFN signaling, with the TYK2 P1104A variant showing differential effects in SSc and COVID-19, alongside novel pleiotropic associations (IRF8, SENP7).
Conclusions:
- Confirmed genetic resemblance between COVID-19 susceptibility/severity and SSc.
- Revealed a novel common genetic contribution impacting fibrotic and immune pathways.
- Identified potential therapeutic avenues for managing both COVID-19 and SSc.
Objectives:
Coronavirus disease 2019 (COVID-19) and SSc share multiple similarities in their clinical manifestations, alterations in immune response and therapeutic options. These resemblances have also been identified in other immune-mediated inflammatory diseases where a common genetic component has been found. Thus, we decided to evaluate for the first time this shared genetic architecture with SSc.
Methods:
For this study, we retrieved genomic data from two European-ancestry cohorts: 2 597 856 individuals from The COVID-19 Host Genetics Initiative consortium, and 26 679 individuals from the largest genomic scan in SSc. We performed a cross-trait meta-analyses including >9.3 million single nucleotide polymorphisms. Finally, we conducted functional annotation to prioritize potential causal genes and performed drug repurposing analysis.
Results:
Our results revealed a total of 19 non-HLA pleiotropic loci, including 2 novel associations for both conditions (BMP1 and PPARG) and 12 emerging as new shared loci. Functional annotation of these regions underscored their potential regulatory role and identified potential causal genes, many of which are implicated in fibrotic and inflammatory pathways. Remarkably, we observed an antagonistic pleiotropy model of the IFN signalling between COVID-19 and SSc, including the well-known TYK2 P1104A missense variant, showing a protective effect for SSc while being a risk factor for COVID-19, along with two additional novel pleiotropic associations (IRF8 and SENP7). Finally, our findings provide new therapeutic options that could potentially benefit both conditions.
Conclusion:
Our study confirms the genetic resemblance between susceptibility to and severity of COVID-19 and SSc, revealing a novel common genetic contribution affecting fibrotic and immune pathways.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Single Nucleotide Polymorphisms-SNPs
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Pleiotropy

